Molecular interactions of SHP1 and SHP2 in IL-3-signalling.
暂无分享,去创建一个
[1] M. Welham,et al. Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3'-kinase. , 1994, The Journal of biological chemistry.
[2] S. Orkin,et al. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development , 1997, Molecular and cellular biology.
[3] D. Barford,et al. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Coffer,et al. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. , 1998, Cellular signalling.
[5] K. Siminovitch,et al. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. , 2000, Seminars in immunology.
[6] B. Neel,et al. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Welham,et al. Interleukin-3 Induces Association of the Protein-tyrosine Phosphatase SHP2 and Phosphatidylinositol 3-Kinase with a 100-kDa Tyrosine-phosphorylated Protein in Hemopoietic Cells* , 1997, The Journal of Biological Chemistry.
[8] A. Miyajima,et al. Molecular structure of the IL-3, GM-CSF and IL-5 receptors. , 1992, International journal of cell cloning.
[9] J. C. Pratt,et al. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. , 1998, Molecular cell.
[10] A. Ullrich,et al. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. , 1993, Science.
[11] J. Tavernier,et al. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF , 1991, Cell.
[12] K. Siminovitch,et al. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. , 1994, Clinical immunology and immunopathology.
[13] T. Kurosaki,et al. Requirement of SH2-containing Protein Tyrosine Phosphatases SHP-1 and SHP-2 for Paired Immunoglobulin-like Receptor B (PIR-B)–mediated Inhibitory Signal , 1998, The Journal of experimental medicine.
[14] A. Ullrich,et al. PTP1D is a positive regulator of the prolactin signal leading to beta‐casein promoter activation. , 1996, The EMBO journal.
[15] J. Olefsky,et al. Expression of Dominant Negative Mutant SHPTP2 Attenuates Phosphatidylinositol 3′-Kinase Activity via Modulation of Phosphorylation of Insulin Receptor Substrate-1 (*) , 1996, The Journal of Biological Chemistry.
[16] M. Gadina,et al. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. , 1998, Journal of immunology.
[17] M. Welham,et al. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways. , 1992, Journal of immunology.
[18] Z. Zhao,et al. Crystal Structure of the Catalytic Domain of Protein-tyrosine Phosphatase SHP-1* , 1998, The Journal of Biological Chemistry.
[19] T. Pawson,et al. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. , 1993, Science.
[20] C. Chen,et al. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] V. Duronio,et al. Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. , 1994, The Journal of biological chemistry.
[22] M. Steinmetz,et al. IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo , 1985, Cell.
[23] M. Quon,et al. Protein-tyrosine Phosphatases PTP1B and Syp Are Modulators of Insulin-stimulated Translocation of GLUT4 in Transfected Rat Adipose Cells* , 1997, The Journal of Biological Chemistry.
[24] G. Krystal,et al. Interleukin-3 Induces the Association of the Inositol 5-Phosphatase SHIP with SHP2* , 1997, The Journal of Biological Chemistry.
[25] T. Pawson,et al. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. , 1994, The Journal of biological chemistry.
[26] J. Ihle,et al. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis , 1993, Molecular and cellular biology.
[27] Ursula Klingmüller,et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.
[28] K. Arai,et al. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors , 1991, Cell.
[29] M. Welham,et al. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates. , 1997, The Journal of biological chemistry.
[30] M. Cooper,et al. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Saito,et al. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells. , 1997, Biochemical and biophysical research communications.
[32] M. Welham,et al. Shc associates with the IL-3 receptor β subunit, SHIP and Gab2 following IL-3 stimulation , 2000 .
[33] A. Ullrich,et al. Both SH2 Domains Are Involved in Interaction of SHP-1 with the Epidermal Growth Factor Receptor but Cannot Confer Receptor-directed Activity to SHP-1/SHP-2 Chimera* , 1997, The Journal of Biological Chemistry.
[34] S. Shoelson,et al. Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.
[35] T. Adachi,et al. Src Homology 2 Protein Tyrosine Phosphatase (SHPTP2)/Src Homology 2 Phosphatase 2 (SHP2) Tyrosine Phosphatase Is a Positive Regulator of the Interleukin 5 Receptor Signal Transduction Pathways Leading to the Prolongation of Eosinophil Survival , 1997, The Journal of experimental medicine.
[36] Z. Zhao,et al. Structural Basis for Substrate Specificity of Protein-tyrosine Phosphatase SHP-1* , 2000, The Journal of Biological Chemistry.
[37] M. Kasuga,et al. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. , 1994, Molecular and cellular biology.
[38] A. Saltiel,et al. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. , 1994, The Journal of biological chemistry.
[39] G. Feng,et al. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation , 1998, Oncogene.
[40] C. Walsh,et al. Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains (*) , 1995, The Journal of Biological Chemistry.
[41] A. Ullrich,et al. A family of proteins that inhibit signalling through tyrosine kinase receptors , 1997, Nature.
[42] B. Neel,et al. Protein tyrosine phosphatases in signal transduction. , 1997, Current opinion in cell biology.
[43] G. Feng,et al. Molecular Characterization of Specific Interactions between SHP-2 Phosphatase and JAK Tyrosine Kinases* , 1997, The Journal of Biological Chemistry.
[44] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[45] S. Harrison,et al. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2 , 1996, Nature.
[46] T. Pawson,et al. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice , 1993, The Journal of experimental medicine.
[47] M. Tremblay,et al. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model. , 1998, Biochemistry.
[48] B. Neel,et al. Characterization of Two SHP-2-associated Binding Proteins and Potential Substrates in Hematopoietic Cells* , 1997, The Journal of Biological Chemistry.
[49] O. Miura,et al. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. , 1995, Blood.
[50] D. Beier,et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.
[51] B. Neel,et al. New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway , 2000, Molecular and Cellular Biology.
[52] J. Ihle,et al. Interleukin-3 and hematopoiesis. , 1992, Chemical immunology.
[53] J. Cleveland,et al. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] Jonathan A. Cooper,et al. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase , 1994, Molecular and cellular biology.
[55] J. Chen,et al. Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. , 2001, Blood.
[56] A. Saltiel,et al. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Siminovitch,et al. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene , 1993, Nature Genetics.
[58] L. Borysiewicz,et al. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. , 1999, Journal of immunology.
[59] H. Broxmeyer,et al. Involvement of SH2-containing Phosphotyrosine Phosphatase Syp in Erythropoietin Receptor Signal Transduction Pathways (*) , 1995, The Journal of Biological Chemistry.
[60] B. Neel,et al. Structural Determinants of SHP-2 Function and Specificity in Xenopus Mesoderm Induction , 1998, Molecular and Cellular Biology.
[61] T. Pawson,et al. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. , 1993, The Journal of biological chemistry.
[62] B. Neel,et al. Identification of Major Binding Proteins and Substrates for the SH2-Containing Protein Tyrosine Phosphatase SHP-1 in Macrophages , 1998, Molecular and Cellular Biology.
[63] Jing Jiang,et al. Involvement of the Src Homology 2-containing Tyrosine Phosphatase SHP-2 in Growth Hormone Signaling* , 1998, The Journal of Biological Chemistry.
[64] S. Shoelson,et al. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. , 1994, The Journal of biological chemistry.
[65] T. Pawson,et al. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp‐2 , 1997, The EMBO journal.
[66] H. Broxmeyer,et al. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. , 1996, Blood.
[67] D. Cosman. The hematopoietin receptor superfamily. , 1993, Cytokine.
[68] M. Thomas,et al. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences , 1992, Molecular and cellular biology.
[69] B. Neel,et al. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression , 1996, Molecular and cellular biology.
[70] H. Broxmeyer,et al. Biased Suppression of Hematopoiesis and Multiple Developmental Defects in Chimeric Mice Containing Shp-2 Mutant Cells , 1998, Molecular and Cellular Biology.